Fundraising FoxVeraMorph
Mansfield, US · Founded 2022 · Delaware corporation · 1 known investors
Find your way into VeraMorph
Each arrow is one introduction. Sign up to fill in the first one.
Ask Karen Kerr to introduce you to Doug Godfrin
You →Karen · together at National Institute of Standards and Technology →Doug
Sign up to find every way you can get introduced to VeraMorph
- Your email: who you already know at VeraMorph, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the VeraMorph team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
VeraMorph is a drug delivery company that has developed a proprietary oral drug delivery platform used to improve solubility and clinical translation of poorly soluble compounds. It works with pharmaceutical companies and is building a portfolio of clinically differentiated oral versions of approved drugs.
Founders & leadership
VeraMorph was founded in 2022 by Paul D. Godfrin and Doug Godfrin.
Investors · 1
Reported raises · per SEC filings
Form D private placements$262.3K disclosed across 2 rounds · 2022–2023
▶$40KraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
- Paul D. GodfrinExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $40K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$222.3KraisedAug 2022 · 2 investors · BiotechnologyRule 506(b)
- Paul D. GodfrinExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $222.3K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does VeraMorph do?
- VeraMorph is a drug delivery company that has developed a proprietary oral drug delivery platform used to improve solubility and clinical translation of poorly soluble compounds. It works with pharmaceutical companies and is building a portfolio of clinically differentiated oral versions of approved drugs.
- Who founded VeraMorph?
- VeraMorph was founded by Paul D. Godfrin, Doug Godfrin in 2022.
- Who are VeraMorph's investors?
- VeraMorph's investors include The Innovation Space.
- How much funding has VeraMorph raised?
- VeraMorph has disclosed $262.3K raised across 2 rounds.
- Where is VeraMorph headquartered?
- VeraMorph is headquartered in Mansfield, US.